Идёт набор NCT06940960
JY231(JY231) Injection for the Treatment of Relapsed/Refractory B Cell Lymphoma/ Leukemia
B Acute Lymphoblastic Leukemia · B-Non Hodgkin Lymphoma
Гематология
3 640 исследований в этом разделе
Набор скоро начнётся NCT07012980
Glofitamab, Polatuzumab Vedotin and Zanubrutinib in First-line Elderly DLBCL
Diffuse Large B-Cell Lymphoma
Идёт набор NCT07010237
Dose-attenuated IST and Hetrombopag in Elderly (≥65 Years) Patients With Severe Aplastic Anemia
Sever Aplastic Anaemia · Elderly (People Aged 65 or More) · Immunosuppressive Treatment
Набор скоро начнётся NCT07008053
BR Combined With OR in Treatment-naïve Marginal Zone Lymphoma
Marginal Zone Lymphomas
Идёт набор NCT05541341
Effectiveness and Safety of Tisagenlecleucel Therapy in Brazilian Patients With B-lymphocyte Malignancies
Diffuse Large B-cell Lymphoma · Acute Lymphoblastic Leukemia · Follicular Lymphoma
Идёт набор NCT07007949
a New Treatment of Newly Diagnosed IDH1 Mutation Acute Myeloid Leukemia
Acute Myeloid Leukemia · IDH1 Gene Mutation · Ivosidenib
Идёт набор NCT06717113
A Molecular Probe Targeting BCMA for the Clinical Diagnosis of Multiple Myeloma
Multiple Myeloma and Malignant Plasma Cell Neoplasms
Идёт набор NCT03104491
Inotuzumab Ozogamicin Post-Transplant For Acute Lymphocytic Leukemia
Acute Lymphocytic Leukemia
Идёт набор NCT06175000
Maintenance Obinutuzumab in Treating Patients With Central Nervous System Lymphoma Who Have Achieved a Complete or Partial Response
Primary Central Nervous System Lymphoma
Идёт набор NCT06742502
Sintilimab Plus Rituximab Followed by R-CHOP Regimen in Untreated PMBL
Primary Mediastinal Diffuse Large B-cell Lymphoma
Идёт набор NCT06119269
Ponatinib in Chronic Myeloid Leukemia Patients in Chronic Phase
Chronic Myeloid Leukemia, Chronic Phase
Идёт набор NCT06793410
Vaccination Against Human Papillomavirus (HPV) After Allogeneic Stem Cell Transplantation
Recipients of Allogeneic Stem Cell Transplantation · HPV (Human Papillomavirus)-Associated · Acute Myeloid Leukaemia
Набор скоро начнётся NCT07003178
A Study to Evaluate the Safety and Clinical Efficacy of STR-P004
Non Hodgkin Lymphoma
Идёт набор NCT06802055
Efficacy and Safety of Sirolimus With or Without Cyclosporin A in Chinese Patients With Aplastic Anemia Refractory/Intolerant to Cyclosporin A
Aplastic Anaemia
Идёт набор NCT06680661
ABBA CORD: dCBT w/ Abatacept for aGVHD Prophylaxis
Acute Myelogenous Leukemia · Acute Lymphatic Leukemia · Chronic Myelogenous Leukemia
Идёт набор NCT07003737
Blinatumomab Intensification for MRD-Negative Acute B-Cell Lymphoblastic Leukemia Before Allogeneic Hematopoietic Stem Cell Transplantation
Acute Lymphoblastic Leukemia, B-precursor
Набор скоро начнётся NCT07003464
Phase II Trial of Zanubrutinib, Obinutuzumab, Bendamustine (ZGB) as First-Line Therapy for Chronic Lymphocytic Leukemia: A Single-Center Study
Chronic Lymphocytic Leukemia
Идёт набор NCT06130579
Interferon-α for TP53 Myeloid Malignancy Post Allo-HSCT
Myeloid Leukemia · Myelodysplastic Syndromes
Идёт набор NCT06618313
One Trial to Evaluate the Safety, Tolerability and Efficacy of JCXH-213 in Patients With r/r B-NHL
B-Cell Non-Hodgkin Lymphoma-Recurrent · B-Cell Non-Hodgkin Lymphoma-Refractory
Идёт набор NCT06846489
Acalabrutinib Plus Rituximab for the Treatment of Elderly or Low- to Intermediate-Risk Younger Untreated Mantle Cell Lymphoma
Mantle Cell Lymphoma (MCL)
Идёт набор NCT07002099
Selinexor, High-dose Methotrexate, and Rituximab Combined With Radiotherapy for Newly Diagnosed, Transplant-ineligible Patients With Central Nervous System Lymphoma: An Open-label, Single-arm, Multicenter Phase II Study
Lymphomas
Идёт набор NCT06390306
The Efficacy and Safety of Third-generation TKIs Combined With Azacitidine and Bcl-2 Inhibitor in Patients With CML-MBP
Chronic Myeloid Leukemia
Идёт набор NCT06119685
IDP-023 as a Single Agent and in Combination With Antibody Therapies in Patients With Advanced Hematologic Cancers
NHL · Multiple Myeloma · Blood Cancer
Набор скоро начнётся NCT07001397
Study on the Short-term Efficacy and Safety of Recombinant Human Thrombopoietin Combined With Immunosuppressant Sequential Eltrombopag Ethanolamine Dry Suspension in the Treatment of SAA/TD-NSAA
Aplastic Anemias
Идёт набор NCT06547528
A Phase I Study to Investigate the Tolerability and Safety of ONO-4685 Given as Monotherapy in T Cell Lymphoma and CLL/SLL
Relapsed or Refractory T Cell Lymphoma and Chronic Lymphocytic Leukemia/Small Lymphocytic Lymphoma
Идёт набор NCT07000617
A Phase II Study of Dexamethasone, Azacitidine, Pegaspargase and Tislelizumab Plus Radiotherapy for Patients With Stage I/II Extranodal NK/T-cell Lymphoma
NK/T Cell Lymphoma
Идёт набор NCT06423911
Study of Olverembatinib (HQP1351) in Patients With CP-CML
Chronic Myeloid Leukemia · CML · CML, Chronic Phase
Идёт набор NCT02203903
Multi-institutional Prospective Research of Expanded Multi-antigen Specifically Oriented Lymphocytes for the Treatment of VEry High Risk Hematopoietic Malignancies
Relapsed/Refractory Hematopoietic Malignancies, Acute Myeloid Leukemia and MDS
Идёт набор NCT06999954
Shwachman-Diamond Syndrome Global Patient Survey and Partnering Platform
Shwachman-Diamond Syndrome · SDS · IBMF
Идёт набор NCT06999031
A Study to Evaluate CG-105-12 in Patients With Relapsed/Refractory Multiple Myeloma
Relapsed/Refractory · Multiple Myeloma
Идёт набор NCT05036564
Diagnosis; Objective RespOnse; THErApy
Primary CNS Lymphoma
Набор по приглашению NCT03031249
Efficacy and Safety of ATO Plus ATRA in Nucleophosmin-1 Mutated Acute Myeloid Leukemia
AML
Идёт набор NCT06966154
A Phase Ib/II Clinical Study Evaluating the Safety and Efficacy of Tislelizumab in Combination With Golidocitinib and Selinexor for the Treatment of R/R NKTCL
Natural Killer/T-cell Lymphoma · Relapsed or Refractory Lymphoma Including ENKL
Идёт набор NCT06982274
Oral Arsenic With ATRA for Newly Diagnosed Patients With Acute Promyelocytic Leukemia
Acute Promyelocytic Leukemia (APL)
Идёт набор NCT01793168
Rare Disease Patient Registry & Natural History Study - Coordination of Rare Diseases at Sanford
Rare Disorders · Undiagnosed Disorders · Disorders of Unknown Prevalence
Идёт набор NCT04691284
Microbiome in Cancer Patients With High Dose Chemotherapy With Stem Cell Transplantation
Hematologic Neoplasms
Идёт набор NCT04733729
Covid-19 in Hematological Malignancies
COVID-19 Infection in Hematological Malignancies Patients
Идёт набор NCT06696183
Gilteritinib in Combination With Venetoclax and Azacitidine for AML Patients With FLT3 Mutations Ineligible for Intensive Treatment
AML - Acute Myeloid Leukemia
Идёт набор NCT04249830
Stem Cell Transplant From Donors After Alpha Beta Cell Depletion in Children and Young Adults
Hematologic Diseases
Идёт набор NCT06935162
Teclistamab in Previously Treated AL Amyloidosis
AL Amyloidosis
Идёт набор NCT06927466
A Clinical Study to Evaluate the Safety, Tolerability, and Preliminary Efficacy of B019 Injection in Subjects With Relapsed or Refractory B-cell Acute Lymphoblastic Leukemia.
Relapsed or Refractory B-cell Acute Lymphoblastic Leukemia
Идёт набор NCT03117036
Prospective Cohort Study for Lymphoma: Samsung Lymphoma Cohort Study III
Lymphoma, Non-Hodgkin · Lymphoma, Hodgkin
Идёт набор NCT06228794
The Prognostic Value of CPCs Quantified by Flow Cytometry in Patients With Multiple Myeloma: a Prospective, Multicenter Clinical Trial
Multiple Myeloma
Идёт набор NCT05763186
The Right Amount of Purge Useful for Blood Sampling on PiccLine (PiccLine)
Hematology
Идёт набор NCT05759793
A Study of CAR-GPRC5D in Patients With Relapsed/Refractory Multiple Myeloma or Plasma Cell Leukemia
Relapsed/Refractory Multiple Myeloma · Plasma Cell Leukemia
Идёт набор NCT06980155
XP-005 Personalized Vaccine Alone or in Combination With Toripalimab for the Prevention of Relapse After Remission in Acute Myeloid Leukemia
Acute Myeloid Leukemia
Идёт набор NCT06869265
Thiotepa Combined With Busulfan and Fludarabine Conditioning Regimen for Haploidentical Hematopoietic Stem Cell Transplantation in Elderly Patients With High-Risk Acute Myeloid Leukemia
Acute Myeloid Leukemia (AML) · High Risk Acute Myeloid Leukemia(AML) · Relapsed/Refractory Acute Myeloid Leukemia (AML)
Идёт набор NCT06034561
Bortezomib-based Regimen for Refractory or Relapsed Acute Lymphoblastic Leukemia
Acute Lymphoblastic Leukemia, in Relapse · Acute Lymphoblastic Leukemia With Failed Remission
Идёт набор NCT06890065
JY231(JY231) Injection for the Treatment of Relapsed/Refractory B Cell Lymphoma/ Leukemia
B Acute Lymphoblastic Leukemia · B-Non Hodgkin Lymphoma
Набор скоро начнётся NCT06849401
The Safety and Efficacy of VGO-Cs01p in Patients With CD7-positive Relapsed/Refractory Acute T-lymphoblastic Leukemia
T-ALL
Идёт набор NCT06244368
GVM±R in Patients With Relapsed or Refractory Aggressive NHL.
Peripheral T Cell Lymphoma · Diffuse Large B-cell Lymphoma
Идёт набор NCT05949125
Phase 1 Study of Allo-RevCAR01-T-CD123 in Patients With Selected CD123 Positive Hematologic Malignancies
Acute Myeloid Leukemia, in Relapse · Acute Myeloid Leukemia Refractory
Набор по приглашению NCT06697327
Daunorubicin + Cytarabine + Venetoclax in de Novo AML
Leukemia, Myeloid, Acute · Acute Myeloid Leukemia
Идёт набор NCT06971523
A Phase I/II Clinical Study of CTS3497 in Patients With MTAP Deficient Malignacies
Solid Tumor · Lymphoma
Идёт набор NCT05294055
Mecapegfilgrastim With Chemotherapy for Peripheral Blood Stem Cell Mobilization in MM and Lymphoma
Multiple Myeloma · Lymphoma
Идёт набор NCT05124288
Analysis of the Immunobiology of Acute Myeloid Leukemia Relapses After Allogeneic Hematopoietic Stem Cell Transplant (HSCT) for the Generation of Guidelines and Personalized Therapeutic Pathways
Acute Myeloid Leukemia, in Relapse
Идёт набор NCT05882175
Prospective Validation of the OHI Index
HLH · Hemophagocytic Lymphohistiocytoses · Hemophagocytic Syndrome
Идёт набор NCT05062707
Early Ageing During Therapy in AYA Cancer Patients
Cancer · Leukemia · Hodgkin Lymphoma
Идёт набор NCT06634394
APVO436 Phase 1b/2 Study in Patients With Newly Diagnosed AML
Acute Myeloid Leukemia (AML)
Набор скоро начнётся NCT06964971
Treatment of Transfusion-dependent Nonsevere Aplastic Anemia With Luspatercept: a Multicenter Prospective Clinical Study
Transfusion-dependent Non-severe Aplastic Anemia
Набор скоро начнётся NCT06963632
A Real-world Study on Golidocitinib-based Therapeutic Regimens for the Treatment of Patients With Peripheral T-cell Lymphoma
Peripheral T-cell Lymphoma (PTCL)
Набор скоро начнётся NCT06961500
Obinutuzumab With CHOP Versus Obinutuzumab With Bendamustine in the Treatment of Newly Diagnosed Follicular Lymphoma Grade 3A
Follicular Lymphoma Grade 3A
Идёт набор NCT06959732
Zanubrutinib Combined With G-CVP in Previously Untreated FL
Follicular Lymphoma ( FL)
Идёт набор NCT06686108
Demethylating Agents Combined With Venetoclax for High-risk T-cell Lymphoblastic Lymphoma/Leukemia Post-Transplant Relapse Prevention
T-cell Acute Lymphoblastic Leukemia · ALLOGENEIC HEMATOPOIETIC STEM CELL TRANSPLANTATION · Relapse
Идёт набор NCT05959720
Adult Acute Lymphoblastic Leukemia Treated With Pediatric Regimen in Brazil
Acute Lymphoid Leukemia · Minimal Residual Disease · Gene Abnormality
Идёт набор NCT03964480
Prospective Observational International Registry of Patients With Newly Diagnosed Peripheral T Cell Lymphoma.
Peripheral T-Cell Lymphoma
Идёт набор NCT06956755
Registry of Myelodysplastic Syndromes and Therapy-related Acute Myeloid Leukemia
Myelodysplastic Syndromes · Leukemia, Myeloid, Acute
Идёт набор NCT04776824
Swiss Cardiac Amyloidosis REgistry (Swiss-CARE)
Amyloid Cardiomyopathy
Набор по приглашению NCT02646839
KIR Favorable Mismatched Haplo Transplant and KIR Polymorphism in ALL/AML/MDS Allo-HCT Children
Acute Lymphoblastic Leukemia · Acute Myeloid Leukemia · Myelodysplastic Syndromes
Идёт набор NCT06222164
The Use of Residual De-identified Specimens and/or Samples From Patients for Clinical Research
Hematologic Diseases
Идёт набор NCT03509961
The EndRAD Trial: Eliminating Total Body Irradiation (TBI) for NGS-MRD Negative Children, Adolescents, and Young Adults With B-ALL
B-cell Acute Lymphoblastic Leukemia
Набор по приглашению NCT04836390
Donor-Derived Ex-Vivo Expanded Natural Killer Cell Infusions in Children and Young Adults With High Risk Acute Myeloid Leukemia Receiving Myeloablative HLA-Haploidentical Hematopoietic Cell Transplant
Acute Myeloid Leukemia
Набор скоро начнётся NCT06956092
Glofitamab for Consolidation After First-line Treatment of High-risk Large B-cell Lymphoma
B Cell Lymphoma (BCL)
Набор скоро начнётся NCT06955858
Clinical Study of rhTPO in Hematopoietic Stem Cell Mobilization for Autologous Transplantation in Acute Leukemia
Hematopoietic Stem Cell Mobilization
Идёт набор NCT06379945
Unified platforM for a Better integRal Evaluation of MyeLodyspLastic Syndromes in SpAin-Strategy for Unraveling Personalized genoMic Medicine in Public heAlth System (UMBRELLA-SUMMA)
Myelodysplastic Syndromes
Идёт набор NCT06382844
Novel Flow-cytometry Approaches to Improve the Detection of Tumor Cells in CTCL
Cutaneous T-Cell Lymphoma
Набор скоро начнётся NCT06953739
A Study Comparing of P-GEMD Regimen Versus P-Gemox Regimen With Untreated Early-Stage NUAT or Advanced-Stage ENKTL.
NK-T-Cell Lymphoma, Extranodal
Идёт набор NCT05908409
A Phase 1/2 Study of IDP-121 in Patients With Relapsed/Refractory Hematologic Malignancies
Multiple Myeloma (MM) · Diffuse Large B-Cell Lymphoma, Not Otherwise Specified · Double Hit Lymphoma
Идёт набор NCT05863234
Safety Evaluation Study for Patients With Aggressive NK-cell Leukemia
Aggressive NK Cell Leukemia
Идёт набор NCT02952144
Post Approval Study of Lixelle for the Treament of Dialysis-Related Amyloidosis
Dialysis Amyloidosis
Идёт набор NCT06061094
Randomized Trial in Adult de Novo Ph Positive ALL With Chemotherapy, Imatinib or Ponatinib, Blinatumomab and SCT
Philadelphia Chromosome Positive Acute Lymphoblastic Leukemia
Идёт набор NCT05943067
CD45RA Depleted DLI After TCRα/β Depleted Haploidentical HCT
Hematologic Malignancy
Идёт набор NCT06947044
Biomarkers in Patients With Anemia-Induced Thrombocytopenic Bleeding
Acute Leukemia · Acute Myeloid Leukemia (AML) · Acute Lymphocytic Leukaemia
Идёт набор NCT06946407
Rituximab, Methotrexate, and Tepadina Induction Followed by Etoposide and Cytarabine Consolidation in Primary Central Nervous System Lymphoma
Primary Central Nervous System Lymphoma (PCNSL) · CNS Lymphoma Treatment
Набор скоро начнётся NCT06830733
Study to Evaluate the Safety and Efficacy of ARI0002h, for the Initial Treatment of Patients With Primary Plasma Cell Leukaemia
Leukemia, Plasma Cell
Идёт набор NCT03571568
A Study of BI-1206 in Combination With Rituximab With or Without Acalabrutinib in Subjects With Indolent B-Cell NHL
Indolent B-Cell Non-Hodgkin Lymphoma
Идёт набор NCT04920968
Obinutuzumab Versus Rituximab for Acute Lymphoblastic Leukemia/PALG ALL7 "OVERALL"
CD20-positive Acute Lymphoblastic Leukemia
Идёт набор NCT06699394
Prospective Study of Teclistamab in the Treatment of Systemic AL Amyloidosis
AL Amyloidosis
Идёт набор NCT06125483
TBI/Flu/Bu/Mel Combined With Secondary UCBT in Patients With Hematological Malignancies Who Relapsed After Allo-HSCT
Hematopoietic Malignancy · Relapse/Recurrence · Hematopoietic Stem Cell Transplantation
Идёт набор NCT06297941
Study of REM-422 in Patients With AML or Higher Risk MDS
Myelodysplastic Syndromes · Higher Risk Myelodysplastic Syndromes · Acute Myeloid Leukemia
Идёт набор NCT05209620
Orelabrutinib Combined With Pemetrexed For Relapsed/Refractory Central Nervous System Lymphoma
Central Nervous System Lymphoma
Идёт набор NCT04263935
Correlation Between Driver Gene Abnormalities and Clinicopathological Characteristics and Disease Prognosis in Lymphoma
Lymphoma · Gene Abnormality
Набор скоро начнётся NCT06931704
Comparison of Elranatamab and Lenalidomide Versus Daratumumab and Lenalidomide as Post-transplant Maintenance Therapy in Patients With Newly Diagnosed Myeloma (ElMMA)
Multiple Myeloma
Идёт набор NCT04737889
Rituximab, Lenalidomide Combined With Methotrexate and Temozolomide For Primary Central Nervous System Lymphoma
Primary Central Nervous System Lymphoma
Идёт набор NCT06937554
Evaluation of Functional and Nutritional Parameters in Fit Acute Leukemia Patients
Acute Leukemia
Идёт набор NCT05956457
PRO and Wearable Data Insights From Individuals With R/R Multiple Myeloma
Multiple Myeloma · Relapsed Hematologic Malignancy
Набор по приглашению NCT06931613
Autologous Hematopoietic Stem Cell Transplantation in Pediatric Relapsed or Refractory Hodgkin Lymphoma After Nivolumab Treatment
Relapsed or Refractory Hodgkin Lymphoma · Children · Nivolumab
Идёт набор NCT06355583
Intestinal Microbiota Transplant Prior to Allogeneic Stem Cell Transplant (MAST) Trial
Acute Lymphoblastic Leukaemia · Acute Leukemia of Ambiguous Lineage · Chronic Myeloid Leukemia
Идёт набор NCT06118788
Phase I Clinical Study: BG1805 Injection in the Treatment of Relapsed or Refractory Acute Myeloid Leukemia
Leukemia, Myeloid, Acute
Идёт набор NCT06140966
Study to Evaluate the Safety and Efficacy of Daratumumab and Carfilzomib-based Induction/Consolidation/Maintenance Therapy in Transplant-eligible, Ultra High-risk, Newly Diagnosed Multiple Myeloma
Multiple Myeloma · Primary Plasma Cell Leukemia · Extramedullary Multiple Myeloma